ERBB2 and breast cancer: Two sizable scRNA-seq breast cancer atlases were used to train, and independently test (Supplementary Data 4, 5) a classification model that resolves breast cancer cells into the major ER + , HER2 + and triple negative breast cancer (TN) histological subtypes.